US Patent Issued to Gruenenthal on July 21 for "Sulfoximines as inhibitors of NaV1.8" (German Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,726, issued on July 21, was assigned to Gruenenthal GmbH (Germany).

"Sulfoximines as inhibitors of NaV1.8" was invented by Marcel Muelbaier (Aachen, Germany), Sebastian Krueger (Aachen, Germany), Clemens Dialer (Aachen, Germany), Mauro Marigo (Aachen, Germany) and Vipulkumar Patel (Aachen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds according to general formula (I)act as inhibitors of NaV1.8 and can be used in the treatment of pain."

The patent was filed on Dec. 14, 2023, under Application No. 18/540,502.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect...